Kintara Therapeutics Inc (KTRA)
0.1844
0.00 (0.00%)
USD |
NASDAQ |
May 22, 16:00
0.1756
-0.01
(-4.77%)
After-Hours: 20:00
Kintara Therapeutics Net Income (TTM): -9.331M for March 31, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -9.331M |
| December 31, 2023 | -10.58M |
| September 30, 2023 | -13.02M |
| June 30, 2023 | -14.65M |
| March 31, 2023 | -16.76M |
| December 31, 2022 | -18.85M |
| September 30, 2022 | -21.29M |
| June 30, 2022 | -22.66M |
| March 31, 2022 | -23.95M |
| December 31, 2021 | -25.23M |
| September 30, 2021 | -24.75M |
| June 30, 2021 | -38.30M |
| March 31, 2021 | -35.39M |
| December 31, 2020 | -30.71M |
| September 30, 2020 | -27.04M |
| June 30, 2020 | -9.126M |
| March 31, 2020 | -7.886M |
| December 31, 2019 | -7.593M |
| September 30, 2019 | -7.662M |
| June 30, 2019 | -8.048M |
| March 31, 2019 | -7.843M |
| December 31, 2018 | -9.112M |
| September 30, 2018 | -10.46M |
| June 30, 2018 | -11.14M |
| March 31, 2018 | -11.36M |
| Date | Value |
|---|---|
| December 31, 2017 | -10.30M |
| September 30, 2017 | -8.458M |
| June 30, 2017 | -8.082M |
| March 31, 2017 | -8.937M |
| December 31, 2016 | -8.209M |
| September 30, 2016 | -9.534M |
| June 30, 2016 | -8.865M |
| March 31, 2016 | -5.708M |
| December 31, 2015 | -6.217M |
| September 30, 2015 | -4.647M |
| June 30, 2015 | -4.348M |
| March 31, 2015 | -7.247M |
| December 31, 2014 | -6.464M |
| September 30, 2014 | 1.407M |
| March 31, 2014 | -4.084M |
| December 31, 2013 | -8.291M |
| September 30, 2013 | -7.428M |
| June 30, 2013 | -14.23M |
| March 31, 2013 | -7.414M |
| December 31, 2012 | -0.0115M |
| September 30, 2012 | -0.0192M |
| June 30, 2012 | -0.0189M |
| March 31, 2012 | -0.0247M |
| December 31, 2011 | -0.0254M |
| September 30, 2011 | -0.0291M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-38.30M
Minimum
Jun 2021
-7.593M
Maximum
Dec 2019
-18.64M
Average
-17.81M
Median
Net Income (TTM) Benchmarks
| ARCA biopharma Inc | -6.002M |
| Shockwave Medical Inc | 163.50M |
| Vanda Pharmaceuticals Inc | -4.889M |
| Heron Therapeutics Inc | -80.95M |
| Asensus Surgical Inc | -78.71M |